证券记录 · 已归档季度
TXG
10x Genomics, Inc. · Healthcare · Medical - Healthcare Information Services
13被追踪持有人
0Δ持有人
22.71M持有股份
$512.82M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +7.8% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 153.99K | $11.76M | n/a | n/a |
| Q2 2026 | 113 | +6 | 98.93M | $3.79B | +15 | −8 |
| Q1 2026 | 109 | +3 | 94.02M | $1.99B | +12 | −10 |
| Q4 2025 | 107 | +3 | 97.86M | $1.59B | +4 | n/a |
| Q3 2025 | 19 | -2 | 71.88M | $839.83M | n/a | −3 |
| Q2 2025 | 19 | +1 | 64.66M | $748.72M | +2 | −1 |
| Q1 2025 | 15 | 0 | 30.56M | $266.82M | +1 | −1 |
| Q4 2024 | 15 | +1 | 24.83M | $356.61M | +3 | −2 |
| Q3 2024 | 13 | 0 | 22.71M | $512.82M | +1 | −1 |
| Q2 2024 | 13 | n/a | 21.07M | $409.76M | n/a | n/a |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 10.75M | +15.4% | $242.74M | 2.2% | ▲ Add | 2 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 2.78M | +731.4% | $62.77M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | T. Rowe Price ✦ | 2.52M | -12.5% | $56.81M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 4 | Geode Capital Management ✦ (被动) | 1.82M | +2.4% | $41.01M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Point72 Asset Management ✦ | 1.23M | 新增 | $27.78M | 0.1% | New | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 918.76K | -32.5% | $20.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Capital World Investors ✦ | 793.30K | 0.0% | $17.91M | 0.0% | Held | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 729.03K | +131.3% | $16.37M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 9 | Marshall Wace ✦ | 467.12K | +1219.5% | $10.55M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 10 | Two Sigma Investments ✦ | 337.28K | +146.6% | $7.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | PRIMECAP Management ✦ | 295.40K | +58.1% | $6.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Norges Bank ✦ (被动) | 41.07K | -95.9% | $927,383 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Baillie Gifford ✦ | 40.38K | -98.5% | $911,736 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $27.78M | 0.1% |
已清仓
| Renaissance Technologies | $4.09M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 328 持有人, 124.40M 股份, $2.59B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 22
Saxonov Serge
Officer, Director · 1.00K 股 · $78,228
Sep 22
SULIMAN SHEHNAAZ
Director · 1.22K 股 · $100,542
Sep 22
SULIMAN SHEHNAAZ
Director · 2.27K 股 · $185,391
Sep 22
SULIMAN SHEHNAAZ
Director · 1.32K 股 · $107,082
Sep 22
SULIMAN SHEHNAAZ
Director · 614 股 · $48,820
Sep 22
SULIMAN SHEHNAAZ
Director · 292 股 · $22,833
Sep 22
Saxonov Serge
Officer, Director · 2.80K 股 · $230,622
Sep 22
Saxonov Serge
Officer, Director · 9.90K 股 · $810,071
Sep 22
Saxonov Serge
Officer, Director · 9.30K 股 · $752,401
Sep 22
Saxonov Serge
Officer, Director · 2.00K 股 · $159,239
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Oct 07
SC 13G/A: ARK Investment Management LLC
Sep 08
SC 13G: PRICE T ROWE ASSOCIATES INC /MD/
Aug 14
SC 13G/A: ARK Investment Management LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据